Skip to content

c-Myc-Regulated lncRNA AFAP1-AS1 Promotes Proliferation of Oral Squamous Cell Carcinoma via the miR-655-3p/CCNA2 Axis.

Jul 2026 · Oral Diseases · 0 citations · 20 references
Medicine

TL;DR

Findings suggest that c-Myc-regulated AFAP1-AS1 may contribute to OSCC proliferation through modulation of the miR-655-3p/CCNA2 axis and provide insight into the molecular mechanisms underlying OSCC progression.

Abstract

Objective

This study aimed to investigate the molecular mechanisms by which AFAP1-AS1 promotes proliferation in oral squamous cell carcinoma (OSCC).

Materials And Methods

AFAP1-AS1 expression was examined in OSCC tissues and cell lines. Functional analyses were performed by silencing AFAP1-AS1 in vitro and assessing the resulting changes in CCNA2 expression. Bioinformatic analyses were used to predict microRNAs (miRNAs) potentially interacting with both AFAP1-AS1 and CCNA2, and these interactions were validated using dual-luciferase reporter assays and RNA immunoprecipitation (RIP). Chromatin immunoprecipitation (ChIP) assays were conducted to determine whether c-Myc directly binds to the AFAP1-AS1 promoter, thereby regulating its transcription.

Results

AFAP1-AS1 was significantly upregulated in OSCC tissues and cell lines compared with normal controls. Silencing AFAP1-AS1 led to decreased CCNA2 expression. Both computational predictions and experimental validations indicated that miR-655-3p interacts with AFAP1-AS1 and CCNA2, potentially acting as a regulatory intermediary. ChIP assays further showed that c-Myc directly binds to the promoter region of AFAP1-AS1, suggesting a role in its transcriptional activation.

Conclusion

These findings suggest that c-Myc-regulated AFAP1-AS1 may contribute to OSCC proliferation through modulation of the miR-655-3p/CCNA2 axis and provide insight into the molecular mechanisms underlying OSCC progression.

View source

Similar papers

Open access Jul 2026

LncRNA RASAL2-AS1 serves as a potential biomarker for prognosis and regulates cellular processes via the miR-590-5p/PDCD5 axis and Wnt/β-catenin pathway in cervical cancer

RASAL2-AS1 exerts a tumor-suppressive effect in cervical cancer by functioning as a competing endogenous RNA (ceRNA) that modulates the miR-590-5p/PDCD5 axis and regulates the Wnt/β-catenin pathway.

Ke Yin, Yi Li, Mengying Tang · 0 citations
Open access 2026

LncRNA OTUD6B-AS1 overexpression induces parthanatos in esophageal adenocarcinoma cells by binding to miR-145-5p and promoting AIF expression.

OtUD6B-AS1 suppresses EAC progression by sponging miR-145-5p and upregulating AIF to induce parthanatos activation, and Targeting this ceRNA regulatory axis may be a therapeutic strategy for EAC.

Qingfeng Zheng, Qiu-ping Wu, Yuling Lin et al. · 0 citations
Open access Sep 2026

LncRNA DLGAP1-AS2 promotes ESCC progression and indicates unfavorable prognosis via the miR-101-3p/EZH2 axis

DLGAP1-AS2 acts as a potential biomarker for unfavorable prognosis in ESCC patients and promotes malignant phenotypes of ESCC cells in vitro by regulating the miR-101-3p/EZH2 axis, enhancing proliferation and EMT, while suppressing ferroptosis.

Li-Wei Tang, Yi-Chuan Zhang, Xiang-Ting Cheng · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.